Fatigue and Thermo Sensitivity Affect Physical Activity in Multiple Sclerosis
|
|
|
- Margaret Montgomery
- 10 years ago
- Views:
Transcription
1 Fatigue and Thermo Sensitivity Affect Physical Activity in Multiple Sclerosis Cecilie Fjeldstad 1 Danielle R. Brittain 2 Anette S. Fjeldstad 3 Gabriel Pardo 1 1 MS Center of Oklahoma, NeuroScience Institute, Oklahoma City, OK 2 University of Oklahoma, Norman, OK 3 University of Utah, Salt Lake City, UT KEY WORDS: Relapsing Remitting Ms, Heat Sensitivity, Axonal Damage, Demyelination ABSTRACT Background Thermo sensitivity (TS), characterized by worsening of neurological symptoms due to increased body temperature, is common in individuals with multiple sclerosis (MS). Fatigue is also a common complaint. Both TS and fatigue can lead to decreased participation in physical activity (PA) in this population. Purpose The primary purpose of this study was to determine through self-report if TS and fatigue have any effect of PA levels in individuals diagnosed with MS. Methods Seventy seven men and women between the ages of 22 and 69 with a diagnosis of Multiple Sclerosis according to McDonald criteria participated in this study (μ = 45.2 ± 1.4). Physical activity level was measured by Godin Leisure-Time Exercise Questionnaire, and fatigue by the Fatigue Severity Scale (FSS). TS was recorded by self-report. Results Eighty-three percent of the group reported TS (91.8% of females and 65.2% of males). Individuals that reported TS participated significantly less in physical activity than individuals who did not report TS (p<.05). There was a moderate negative correlation (p<.01) between physical activity and FSS. Significant gender differences were seen for FSS (p<.05), and PA (p<.05), with men reporting less fatigue and more participation in PA than women. Classification of MS did not influence participation in PA or FSS (p>.05). Conclusion Individuals with MS that scored higher on FSS and those that reported TS had lower participation in PA. As for gender differences, men reported less fatigue, more participation in PA, and less occurrence of TS than women (p<.05). According to our results, both TS and fatigue have a negative The Journal of Applied Research Vol.10, No. 3,
2 effect on participation in PA in individuals diagnosed with MS. INTRODUCTION Multiple sclerosis (MS) is a chronic neuro-degenerative inflammatory disease of the central nervous system, and is the most common cause of neurological disability in young adults 1. Historically, people with MS were encouraged not to exercise, as it was observed that symptoms such as fatigue worsened after exercise 2. Although recommendations for physical activity in the healthy population have gained considerable attention, this is not the case for the disabled population 3. Regular physical activity has been recognized as one of the most consistent positive interventions in patients with MS 4 resulting in improved cardiovascular function 5, muscular strength 6, and delaying the early onset of fatigue 7. Therefore, although there have been studies examining the role exercise could potentially play in the treatment and prevention of MS symptoms, the link between exercise and MS has yet to be fully explored. Intolerance to heat resulting from physical activity or increased ambient temperature is very common in MS. As many as 60-80% of people with MS report clinical deterioration resulting from thermo sensitivity 8. An increase of 0.5 C may slow or even block nerve impulse conduction in demyelinated fibers 8. This phenomenon, also called Uhthoff s, manifests as a temporary worsening of neurological function with increased body temperature 9. This worsening usually subsides within 30 minutes following cool down. Although there has been an interest in the role of heat-intolerance 10, the effect of heat-intolerance on exercise in MS still remains somewhat undetermined. Excessive fatigue, described as the feeling of lassitude or lack of energy, is one of the most common complaint in individuals with MS, 11 often leading to a loss of motivation for physical exercise, which in turn results in greater muscle weakness 12 and decreased bone mineral density. 13 This in turn may further result in increased risk of injury through falls and fractures. Indeed, some MS patients feel they need to preserve their energy for essential activities of daily living. The way in which fatigue is both perceived and influences exercise in MS remains largely unexplored. There is a need to better understand the mechanisms responsible for fatigue in patients with MS. This study sought to examine the effect fatigue and perceived thermo sensitivity has on participation in physical activity in patients with MS. We hypothesize that fatigue and perceived thermo sensitivity will result in decreased participation in physical activity. METHODS Participants Participants in this study consisted of 77 men and women between 22 and 69 years of age with a diagnosis of Multiple Sclerosis according to the McDonald criteria 14. All participants were volunteers from the MS Center of Oklahoma, Mercy NeuroScience Institute in Oklahoma City. Research Design This was a correlational study requiring participants to fill out self-report questionnaires in a single session lasting approximately 30 minutes. The study protocol was approved by the institutional review board at Mercy Health Center, and all participants in the study provided written informed consent before testing. Assessments Physical Activity level (PA) Physical activity level was measured by the Godin Leisure-Time Exercise Questionnaire, which consisted of two main questions.15. It determined the average number of times an individual participated in strenuous, moderate and mild exercise, for more than 15 minutes during their free time in a typical 7-day period. Strenuous exercise is considered when the heart beats rapidly and includes activities such as running, jogging, vigorous swimming, and vigorous long distance bicycling. Moderate exercise is considered not ex- 109 Vol.10, No.3, 2010 The Journal of Applied Research.
3 hausting, and includes activities such as fast walking, baseball, tennis, easy bicycling, and easy swimming. Mild exercise is considered minimal effort such as yoga, archery, bowling, golf, and easy walking. It also determines how often during a typical 7-day period an individual engages in any regular activity long enough to work up a sweat. Each participant could answer: 1-often, 2-sometimes, or 3-rarely/never. Total weekly leisure activity is calculated by using the weekly frequencies of strenuous, moderate, and light activities multiplied by nine, five, and three METs, respectively. Fatigue Fatigue was measured by the Fatigue Severity Scale (FSS) 16. The FSS is a method that evaluates fatigue in individuals diagnosed with MS and others that also have conditions such as chronic fatigue immune dysfunction syndrome and systemic lupus erythematosus. FSS is widely used in MS studies and shows high reliability, validity and internal consistency 16. This scale is specifically designed to differentiate fatigue from clinical depression, since both may share common symptoms. A score of 4.5 is on average seen in people with depression alone, but people with fatigue-related MS, score an average of The FSS is a 9-item questionnaire, each item rating from 1-7, and requires the subject to rate his or her own level of fatigue. Each participant was asked to answer the questions depending on how appropriate they felt the statement applied to them over the preceding week. A low value indicates low agreement with the statement whereas a high value indicates high agreement 16. The score is calculated by adding all 9-items and dividing it by 9. Thermo Sensitivity (TS) Thermo sensitivity was recorded by self-report as to whether they experienced thermo sensitivity or not on a yes-or-no basis while participating in physical activity. Demographic Data Questionnaire A questionnaire recording demographic data such as age, height, weight, gender, type of MS, and duration since MS diagnosis was obtained from each participant. Statistical Analysis The results of all descriptive analyses were reported as mean ± standard error for the group. A univariate analysis of variance was used to determine thermo sensitivity group differences in physical activity (ie, Group 1 did experience thermo sensitivity; Group 2 did not experience thermo sensitivity). Chisquare analysis was used to examine gender differences in thermo sensitivity. Pearson product moment correlation coefficients Table I. Subject Characteristics (n = 77; 23 males/54 females) Age (yrs) ± 1.4 Height (cm) ±.01 Weight (kg) ± 2.7 BMI (kg/m²) ±.78 MS (yrs) ±.82 Type of MS RR-MS (n) 61 PP-MS (n) 3 SP-MS (n) 12 CIS (n) 1 Mean ± Standard Error (SE), BMI; body mass index, MS; multiple sclerosis, RR-MS; relapsing remitting MS, PP-MS; primary progressive MS, SP-MS; secondary progressive MS, CIS; clinical isolated syndrome The Journal of Applied Research Vol.10, No. 3,
4 were computed for physical activity and FSS measures. Finally, univariate analysis of variance was used to determine gender differences in PA, TS, and FSS, and whether differences in PA or FSS existed between individuals with different types of MS. Univariate analysis of variance was also used when filtering FSS scores into low and high levels of fatigue. Everyone scoring got coded 0 (or not selected) and everyone scoring 4.5 and above got coded 1 (or selected) in the analysis. All statistical analysis was performed using SPSS, version 16.0 (SPSS Inc, Chicago, IL, USA). Statistical significance was defined as P-value < RESULTS Clinical Characteristics Participants consisted of 77 individuals (23 males/54 females), ranging in age from 22 to 69 years (μ=45.2), with an average disease duration of 7.6 years (range 1 month to 30 years). Subject demographic data are displayed in table I. Thermo Sensitivity (TS) Overall, 83.3% of the participants reported TS (91.8% of females and 65.2% of males). Individuals that reported yes to TS also reported higher FSS scores compared to individuals that reported no to TS (4.9 vs 3.3), indicating a trend that people with Graph I. Physical Activity and Thermo sensitivity TS experience more fatigue compared to people that do not have TS. Individuals that reported TS had significantly lower rates of physical activity participation compared to individuals who did not report TS (p<.05), (Graph I). Fatigue There was a negative correlation (p<.01) between physical activity and FSS, indicating that as levels of fatigue increase, participation in physical activity decrease, (Graph II). Individuals that scored 4.5 or higher on FSS reported significantly less participation in PA (p<.05) compared to those who reported fatigue less than 4.5 on the FSS test. Gender Differences and Type of MS Significant gender differences were seen for FSS (p<.05) and PA (p<.05), with men reporting less fatigue and more participation in PA than women. There were gender differences with women reporting occurrence of TS significantly more often that men (p<.05). Type of MS did not influence participation in PA or FSS (p>.05). DISCUSSION This study examined whether individuals diagnosed with MS participated less in physical activity if they reported being bothered with fatigue or thermo sensitivity. Thermo Sensitivity Participants who reported experiencing thermo sensitivity during physical activity showed markedly less participation in physical activity when compared to individuals who reported not experiencing it. An increase in body temperature, either passively or by exercise, even only by a few degrees, has shown to cause a reduction in CNS activation with core temperature reaching 39.5 C and thereby slowing down the central motor drive to the working muscles 17. There is evidence of decreased maximal motor unit firing rates 18 and inadequate motor unit re- 111 Vol.10, No.3, 2010 The Journal of Applied Research.
5 Graph II. Pearson correlation between Physical Activity and Fatigue severity scale cruitment 19 during maximal voluntary contractions in MS muscles compared to that of normal subjects. This suggests that the neural mechanisms are responsible for the deficit in muscular strength that is seen in MS 20. Combining this with increased body temperature could possibly reduce physical functionality and thereby hasten fatigue, causing greater difficulties with engaging in physical activity. In areas of demyelination, even a small increase (e.g. 0.5 C) in core temperature could completely block action potentials and the affected axons can only transmit single or low frequency impulses 8, 21. Individuals that have a greater fitness level, seem to acclimatize faster and are able to sweat more 22. Studies involving MS response to sweating are scarce even though autonomic dysfunction has been reported 23, as well as lower sweat rate and sweat gland output following aerobic training along with patients with more disease severity compared to that of controls 24,25. An added element is the potential for decreased sweat gland output, which can have a potentiated effect on thermo regulation. The hypothalamus is the temperatureregulating center, and hypothalamic lesions within the CNS could possibly play a role on how well the autonomic temperature regulation functions in an individual with MS. 24 Fatigue Fatigue is one of the most common complaint in individuals with MS 11, with sudden feeling of extreme fatigue for no specific reason, often occurring as the day progresses. The exact etiology of fatigue is unknown, but it might be multifactorial, affecting functioning on several levels and not only by muscular strength weakness 26. The weakness, disability and fear of aggravating their clinical state, may lead these chronically ill patients, who already suffer from fatigue, to magnify this symptom. Both asthenia (fatigue at rest) and pathological fatigability (fatigue upon physical loading) may be translated into a sensation of increased effort to perform even the slightest activity 27. Feelings like these may be a deterrent for patients to participate in any physical activity program. The relationship between physical activity and fatigue however, have shown equivocal results, with some studies reporting no increase in fatigue with physical activity 28 and others reporting increased fatigue with physical activity participation 29. A 24% reduction in self-reported fatigue was reported in a study by White et al. 30 following an eight week progressive resistance training program focusing on lower extremity. This was further supported in a study by Dodd et al. 31 whom also reported reduced fatigue following a progressive resistance exercise program twice weekly for 10 weeks in MS individuals. Fatigue may affect participation in physical activity, which coincides with the results of our study that showed significantly less participation in physical activity with increased fatigue in individuals with MS. Induction of fatigue with increased body temperature was demonstrated by Baker 32 in a study in which MS patients exercising in a pre-heated pool experienced greater symptoms of exhaustion. Significant improvement in 25-ft walk performance and fatigue scores were demonstrated in a different The Journal of Applied Research Vol.10, No. 3,
6 study following pre-cooling in a pool prior to exercise. 33 Although, with sudden onset of MS-related fatigue, any physical task may take considerable effort to execute, so reducing the thermal strain may help attenuate fatigue and also the reduction of participation in physical activity. Gender Differences In relation to gender differences and heatrelated issues, reports have suggested, although with some controversy, that most women appear to be less heat tolerant than men, which coincides with the results of this study. A possible explanation is that women generally have higher percentage of body fat, which reduces heat loss. 34 Type of MS Type of MS did not influence PA or FSS in our study. However, a study by Cartlidge 25 found impaired sweat function in MS patients with more severe disease progression. In our study, we demonstrated that MS individuals that reported issues with thermo regulation also reported significantly less participation in PA. CONCLUSION These findings provide a framework for future studies of physical activity and the relationship to fatigue and thermo sensitivity in the MS population. With both thermo sensitivity and fatigue negatively affect participation of physical activity, future research should include ways to prevent thermo sensitivity in order to increase participation in physical activity in this population. Cooling equipment to minimize heat related problems, such as cooling vests or pre-cooling by water immersion, have shown beneficial results with balance and gait 35, improved visual field in individuals with acute optic neuritis 36, reduced spasticity 37, as well as improvement in fatigue 38. Since it has been proven that cooler temperatures improves both neurologic function and fatigue, exercise programs should be monitored and performed in a cool controlled environment to be most beneficial. Another way to control for minimal increase in core temperature is with resistance training as the chosen type of physical activity, as it does not result in the same increases in core temperatures that is seen with endurance training 20. Further, pharmaceuticals such as potassium channel blockers like 4-aminopyridine (4-AP) have shown to improve motor and visual function and walking speed 42 in MS patients by increasing the conduction of action potentials in demyelinated fibers 43. Another way to control for minimal increase in core temperature is with resistance training as the chosen type of physical activity, as it does not result in the same increases in core temperatures that is seen with endurance training. 20 Further, pharmaceuticals such as potassium channel blockers called 4-aminopyridine (4-AP) haveshown to improve motor and visual function and walking speed 42 in MS patients by increasing the conduction of action potentials in demyelinated fibers. 43 This may be even more important to follow for female MS patients, as women may be less tolerant to heat compared to men, which also coincides with this study with more women reporting heat sensitivity than what men did. Study Limitations and Future Studies Paragraph Number 23 This study was based on results of selfreport and can therefore not be generalized to the entire MS population and can have the bias of improper recollection. However, the sample size was large enough to draw general conclusions on what affects participation in physical activity in an MS population. Future studies should be done to include objective measures of heat sensitivity and fatigue by perhaps measuring force generation or maximal voluntary muscle contraction, in order to get a better understanding of more effective therapeutic strategies to treat MS symptoms, reduce the incidence of secondary diseases such as cardiovascular diseases and obesity and also improve functional independence. REFERENCES 1. Kraft AM, Wessman HC. Pathology and etiology in multiple sclerosis: a review. Phys Ther Vol.10, No.3, 2010 The Journal of Applied Research.
7 Jul;54: 7: Petajan JH, White AT. Recommendations for physical activity in patients with multiple sclerosis. Sports Med Mar;27 (3): Ginis KA, Hicks AL. Considerations for the development of a physical activity guide for Canadians with physical disabilities. Can J Public Health. 2007;98 Suppl 2: S Kos D, Kerckhofs E, Nagels G, D Hooghe M B, Ilsbroukx S. Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair Jan-Feb;22 (1): Mostert S, Kesselring J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler Apr ;8 (2): White LJ, Castellano V, Mc Coy SC. Cytokine responses to resistance training in people with multiple sclerosis. J Sports Sci Aug;24 (8): Sheean GL, Murray NM, Rothwell JC, Miller DH, Thompson AJ. An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain Feb;120 ( Pt 2): Guthrie TC, Nelson DA. Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential. J Neurol Sci Mar; 129 (1): Selhorst JB, Saul RF. Uhthoff and his symptom. J Neuroophthalmol Jun;15 (2): van Diemen HA, van Dongen MM, Dammers JW, Polman CH. Increased visual impairment after exercise (Uhthoff s phenomenon) in multiple sclerosis: therapeutic possibilities. Eur Neurol. 1992;32 (4): Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil Mar ;65 (3): Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol Apr;45 (4): White LJ, Dressendorfer RH. Exercise and multiple sclerosis. Sports Med. 2004;34 (15): McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol Jul ;50 (1): Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci Sep;10 (3): Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol Oct;46 (10): Saboisky J, Marino FE, Kay D, Cannon J. Exercise heat stress does not reduce central activation to non-exercised human skeletal muscle. Exp Physiol Nov;88 (6): Rice CL, Vollmer TL, Bigland-Ritchie B. Neuromuscular responses of patients with multiple sclerosis. Muscle Nerve Oct;15 (10): Sharma KR, Kent-Braun J, Mynhier MA, Weiner MW, Miller RG. Evidence of an abnormal intramuscular component of fatigue in multiple sclerosis. Muscle Nerve Dec;18 (12): Dalgas U, Stenager E, Ingemann-Hansen T. Multiple sclerosis and physical exercise: recommendations for the application of resistance-, enduranceand combined training. Mult Scler Jan;14 (1): Schauf CL, Davis FA. Impulse conduction in multiple sclerosis: a theoretical basis for modification by temperature and pharmacological agents. J Neurol Neurosurg Psychiatry Feb;37 (2): Pandolf KB. Effects of physical training and cardiorespiratory physical fitness on exercise-heat tolerance: recent observations. Med Sci Sports Sping;11 (1): Noronha MJ, Vas CJ, Aziz H. Autonomic dysfunction (sweating responses) in multiple sclerosis. J Neurol Neurosurg Psychiatry Feb;31 (1): Marino FE. Heat reactions in multiple sclerosis: an overlooked paradigm in the study of comparative fatigue. Int J Hyperthermia Feb;25 (1): Cartlidge NE. Autonomic function in multiple sclerosis. Brain. 1972;95 (4): Comi G, Leocani L, Rossi P, Colombo B. Physiopathology and treatment of fatigue in multiple sclerosis. J Neurol Mar;248 (3): Fragoso YD, Santana DL, Pinto RC. The positive effects of a physical activity program for multiple sclerosis patients with fatigue. NeuroRehabilitation. 2008;23 (2): DeBolt LS, McCubbin, J.A. The Effects of Resistance Training on Fatigue and Depression in Adults With Multiple Sclerosis. Medicine & Science in Sports & Exercise Volume 35, 2003:S Andreasen AK, Jakobsen J, Petersen T, Andersen H. Fatigued patients with multiple sclerosis have impaired central muscle activation. Mult Scler. 2009; Jul 15 (7): White LJ, McCoy SC, Castellano V, et al. Resistance training improves strength and functional capacity in persons with multiple sclerosis. Mult Scler Dec;10 (6): Dodd KJ, Taylor NF, Denisenko S, Prasad D. A qualitative analysis of a progressive resistance exercise programme for people with multiple sclerosis. Disabil Rehabil Sep 30;28 (18): Baker DG. Multiple sclerosis and thermoregulatory dysfunction. J Appl Physiol May;92 (5): White AT, Wilson TE, Davis SL, Petajan JH. Effect of precooling on physical performance in multiple sclerosis. Mult Scler Jun;6 (3): Powers S, Howley, ET. Exercise Physiology. Therory and Application to Fitness and Performance. Third ed The Journal of Applied Research Vol.10, No. 3,
8 35. Syndulko K WA, Baumhefner RW, Tourtellotte WW. Preliminary evaluation of lowering tympanic temperature for the symptomatic treatment of multiple sclerosis. J Neuro Rehab. 1995;9: Heider W, Gottlob I. [A differential diagnostic test for optic neuritis]. Klin Monbl Augenheilkd May;190 (5): Harlaar J, Ten Kate JJ, Prevo AJ, Vogelaar TW, Lankhorst GJ. The effect of cooling on muscle co-ordination in spasticity: assessment with the repetitive movement test. Disabil Rehabil Jul 20;23 (11): Flensner G, Lindencrona C. The cooling-suit: case studies of its influence on fatigue among eight individuals with multiple sclerosis. J Adv Nurs Mar;37 (6): Davis FA, Stefoski D, Rush J. Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis. Ann Neurol Feb;27 (2): Jones RE, Heron JR, Foster DH, Snelgar RS, Mason RJ. Effects of 4-aminopyridine in patients with multiple sclerosis. J Neurol Sci. 1983;60: Stefoski D, Davis FA, Faut M, Schauf CL. 4-Aminopyridine improves clinical signs in multiple sclerosis. Ann Neurol Jan;21 (1): Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, et al. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet Feb 28; : Judge SI, Bever CT, Jr. Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther Jul;111 (1): Vol.10, No.3, 2010 The Journal of Applied Research.
Fatigue in MS: 2005 update B. Colombo University of Milan - HSR
Fatigue in MS: 2005 update B. Colombo University of Milan - HSR Fatigue in MS One of the more disabling symptoms Affects about 75/90 % of the patients May be the onset symptom Transient or chronic May
Multiple Sclerosis (MS) Aprile Royal, Novartis Pharma Canada Inc. September 21, 2011 Toronto, ON
Multiple Sclerosis (MS) Aprile Royal, Novartis Pharma Canada Inc. September 21, 2011 Toronto, ON First-line DMTs Reduce Relapse Frequency by ~30% vs. Placebo Frequency of relapse with various DMTs, based
ß-interferon and. ABN Guidelines for 2007 Treatment of Multiple Sclerosis with. Glatiramer Acetate
ABN Guidelines for 2007 Treatment of Multiple Sclerosis with ß-interferon and Glatiramer Acetate Published by the Association of British Neurologists Ormond House, 27 Boswell Street, London WC1N 3JZ Contents
Wellness for People with MS: What do we know about Diet, Exercise and Mood And what do we still need to learn? March 2015
Wellness for People with MS: What do we know about Diet, Exercise and Mood And what do we still need to learn? March 2015 Introduction Wellness and the strategies needed to achieve it is a high priority
Exercise and FES cycle fact sheet
Exercise and FES cycle fact sheet FES = Functional Electrical Stimulation. An electrical current is passed through paralysed muscle causing it to contract. The electrical current uses the peripheral nerves
Clinically isolated syndrome (CIS)
Clinically isolated syndrome (CIS) Spirella Building, Letchworth, SG6 4ET 01462 476700 www.mstrust.org.uk reg charity no. 1088353 We hope you find the information in this factsheet helpful. If you would
Accuracy in Space and Time: Diagnosing Multiple Sclerosis. 2012 Genzyme Corporation, a Sanofi company.
Accuracy in Space and Time: Diagnosing Multiple Sclerosis 2012 Genzyme Corporation, a Sanofi company. Brought All rights to reserved. you by www.msatrium.com, MS.US.PO876.1012 your gateway to MS knowledge.
Version History. Previous Versions. Drugs for MS.Drug facts box fampridine Version 1.0 Author
Version History Policy Title Drugs for MS.Drug facts box fampridine Version 1.0 Author West Midlands Commissioning Support Unit Publication Date Jan 2013 Review Date Supersedes/New (Further fields as required
Reversibility of Acute Demyelinating Lesions in relapsingremitting
Reversibility of Acute Demyelinating Lesions in relapsingremitting Multiple Sclerosis Omar A. Khan ( Division of Neuroimmunology, Department of Neurology, Neurology and Research Services. Veterans Affairs
Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012
Medication Policy Manual Policy No: dru283 Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012 Committee Approval Date: December 12, 2014 Next Review Date: December 2015 Effective Date: January
Multiple sclerosis (MS) has been found to
Correlation of Physical Activity with Perceived Cognitive Deficits in Relapsing-Remitting Multiple Sclerosis Ruchika Shaurya Prakash, PhD; Erin M. Snook, PhD; Arthur F. Kramer, PhD; Robert W. Motl, PhD
Mellen Center for Multiple Sclerosis
Mellen Center Cleveland Clinic Marie Namey, RN, MSN, MSCN Mellen Center Cleveland Clinic Cleveland, OH Home of. Mellen Center for Multiple Sclerosis Mellen Center Mission The Mellen Center remains committed
Treatment Optimization in MS: When to Start, When to Shift, when to Stop
Treatment Optimization in MS: When to Start, When to Shift, when to Stop Mark S. Freedman MSc MD FAAN FANA FRCPC Director, Multiple Sclerosis Research Unit University of Ottawa Sr. Scientist, Ottawa Hospital
What is Multiple Sclerosis? Gener al information
What is Multiple Sclerosis? Gener al information Kim, diagnosed in 1986 What is MS? Multiple sclerosis (or MS) is a chronic, often disabling disease that attacks the central nervous system (brain and spinal
A Definition of Multiple Sclerosis
English 182 READING PRACTICE by Alyx Meltzer, Spring 2009 Vocabulary Preview (see bolded, underlined words) gait: (n) a particular way of walking transient: (adj) temporary; synonym = transitory remission:
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Proposed Health Technology Appraisal Daclizumab for treating relapsing-remitting multiple Draft scope (pre-referral) Draft remit/appraisal objective To
Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012
Medication Policy Manual Policy No: dru283 Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012 Committee Approval Date: December 11, 2015 Next Review Date: December 2016 Effective Date: January
New perception of disability including cognition, fatigue, pain and other impairments related to MS
New perception of disability including cognition, fatigue, pain and other impairments related to MS Diego Cadavid, MD Director, MS Clinical Development Biogen Idec 1 Need for clarity on terminology for
Summary Diagnosis and Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in People with Multiple Sclerosis (MS)
ETMIS 2012; Vol. 8: N o 7 Summary Diagnosis and Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in People with Multiple Sclerosis (MS) March 2012 A production of the Institut national d
Altitude. Thermoregulation & Extreme Environments. The Stress of Altitude. Reduced PO 2. O 2 Transport Cascade. Oxygen loading at altitude:
Altitude Thermoregulation & Extreme Environments Reduced PO 2 The Stress of Altitude O 2 Transport Cascade Progressive change in environments oxygen pressure & various body areas Oxygen loading at altitude:
A blood sample will be collected annually for up to 2 years for JCV antibody testing.
Mellen Center Currently Enrolling Non-Treatment Trials STRATIFY-2 JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri Primary Investigator:
MULTIMODAL THERAPY FOR MS- ASSOCIATED COGNITIVE DYSFUNCTION
MULTIMODAL THERAPY FOR MS- ASSOCIATED COGNITIVE DYSFUNCTION Michael K. Racke, MD Professor and Chairman in Neurology The Helen C. Kurtz Chair in Neurology Department of Neurology Ohio State University
Clinical Study Synopsis
Clinical Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website. It is provided for patients and healthcare professionals to increase the transparency of
Clinical features. Chapter 2. Clinical manifestations. Course
Chapter 2 Clinical features Clinical manifestations The wide range of symptoms and signs of multiple sclerosis (MS) reflect multifocal lesions in the central nervous system (CNS), including in the afferent
Exercise Prescription Case Studies
14 Exercise Prescription Case Studies 14 14 Exercise Prescription Case Studies Case 1 Risk Stratification CY CHAN is a 43-year-old man with known history of hypertension on medication under good control.
How To Use A Drug In Multiple Sclerosis
Revised (2009) guidelines for prescribing in multiple sclerosis INTRODUCTION In January 2001, the (ABN) first published guidelines for the use of licensed disease modifying treatments (ß-interferon and
GA-3 Disaster Medical Assistance Team. Physical Fitness Guide
GA-3 Disaster Medical Assistance Team Physical Fitness Guide PURPOSE: The purpose of this Physical Fitness Guide is to provide physical fitness training information to the members of the GA-3 Disaster
adj., departing from the norm, not concentric, utilizing negative resistance for better client outcomes
Why Eccentrics? What is it? Eccentric adj., departing from the norm, not concentric, utilizing negative resistance for better client outcomes Eccentrics is a type of muscle contraction that occurs as the
06/06/2012. The Impact of Multiple Sclerosis in the Pacific Northwest. James Bowen, MD. Swedish Neuroscience Institute
The Impact of Multiple Sclerosis in the Pacific Northwest James Bowen, MD Multiple Sclerosis Center Multiple Sclerosis Center Swedish Neuroscience Institute 1 2 Motor Symptoms of MS Weakness Spasticity
Committee Approval Date: December 12, 2014 Next Review Date: December 2015
Medication Policy Manual Policy No: dru299 Topic: Tecfidera, dimethyl fumarate Date of Origin: May 16, 2013 Committee Approval Date: December 12, 2014 Next Review Date: December 2015 Effective Date: January
Multiple Sclerosis. Matt Hulvey BL A - 615
Multiple Sclerosis Matt Hulvey BL A - 615 Multiple Sclerosis Multiple Sclerosis (MS) is an idiopathic inflammatory disease of the central nervous system (CNS) MS is characterized by demyelination (lesions)
Issues Regarding Use of Placebo in MS Drug Trials. Peter Scott Chin, MD Novartis Pharmaceuticals Corporation
Issues Regarding Use of Placebo in MS Drug Trials Peter Scott Chin, MD Novartis Pharmaceuticals Corporation Context of the Guidance The draft EMA Guidance mentions placebo as a comparator for superiority
AUBMC Multiple Sclerosis Center
AUBMC Multiple Sclerosis Center 1 AUBMC Multiple Sclerosis Center The vision of the American University of Beirut Medical Center (AUBMC) is to be the leading academic medical center in Lebanon and the
Interferons (Avonex, Betaferon, Rebif ) for relapsing remitting multiple sclerosis (RRMS)
Interferons (Avonex, Betaferon, Rebif ) for relapsing remitting multiple sclerosis (RRMS) Review Question: What happens when people with RRMS take interferons? The short answer: This review found that
OHTAC Recommendation
OHTAC Recommendation Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency Presented to the Ontario Health Technology Advisory Committee in May 2010 May 2010 Issue Background A review on the
WHAT IS THE CORE RECOMMENDATION OF THE ACSM/AHA PHYSICAL ACTIVITY GUIDELINES?
PHYSICAL ACTIVITY AND PUBLIC HEALTH GUIDELINES FREQUENTLY ASKED QUESTIONS AND FACT SHEET PHYSICAL ACTIVITY FOR THE HEALTHY ADULT WHAT IS THE CORE RECOMMENDATION OF THE ACSM/AHA PHYSICAL ACTIVITY GUIDELINES?
Progress in MS: Current and Emerging Therapies
Progress in MS: Current and Emerging Therapies Presented by: Dr. Kathryn Giles, MD MSc FRCPC The MS Society gratefully acknowledges the grant received from Biogen Idec Canada, which makes possible the
The Prospect of Stem Cell Therapy in Multiple Sclerosis. Multiple sclerosis is a multifocal inflammatory disease of the central
The Prospect of Stem Cell Therapy in Multiple Sclerosis Multiple sclerosis is a multifocal inflammatory disease of the central nervous system that generally affects young individuals, causing paralysis
Physical Therapy Perspective on Ataxia. Roger Fong, MPT University of Chicago Medical Center March, 2010
Physical Therapy Perspective on Ataxia Roger Fong, MPT University of Chicago Medical Center March, 2010 Definition: Physical Therapist Physical therapy dynamic profession with an established theoretical
Autoimmune Diseases More common than you think Randall Stevens, MD
Autoimmune Diseases More common than you think Randall Stevens, MD picture placeholder Autoimmune Diseases More than 60 different disorders Autoimmune disorders (AID) diseases caused by the immune system
DIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria
DIABETES MELLITUS By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria What is Diabetes Diabetes Mellitus (commonly referred to as diabetes ) is a chronic medical
Therapeutic Canine Massage
Meet our Certified Canine Massage Therapist, Stevi Quick After years of competitive grooming and handling several breeds in conformation, I became interested in training and competing with my dogs in the
Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics
Mitzi Joi Williams, MD Neurologist MS Center of Atlanta, Atlanta, GA Disclosures Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics
MEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION. POLICY NUMBER: 8.01.19 CATEGORY: Therapy/Rehabilitation
MEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical
Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas
Billing and Coding in Neurology and Headache Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas CPT Codes vs. ICD Codes Category
Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years
Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957
Natalizumab (Tysabri) and PMLthe current figures. Paul-Ehrlich-Institut Brigitte Keller Stanislawski Paul-Ehrlich-Str. 51-59 63225 Langen GERMANY
Natalizumab (Tysabri) and PMLthe current figures Paul-Ehrlich-Institut Brigitte Keller Stanislawski Paul-Ehrlich-Str. 51-59 63225 Langen GERMANY Humanised MAB Natalizumab Specific binding to a4-integrin
Novel therapeutic approaches in multiple sclerosis Neuroprotective and remyelinating agents, the future of clinical trials in MS?
Novel therapeutic approaches in multiple sclerosis Neuroprotective and remyelinating agents, the future of clinical trials in MS? Marie Trad, M.D., Lynne Hughes, Cathy VanBelle, Amy Del Medico 3rd International
PRO BALLOON VENOPLASTY IS A PROMISING TECHNOLOGY FOR TREATMENT OF MS
PRO BALLOON VENOPLASTY IS A PROMISING TECHNOLOGY FOR TREATMENT OF MS Manish Mehta MD MPH The Vascular Group The Institute for Vascular Health & Disease Albany Medical Center SVS 2012 DISCLOSURES Research,
FastTest. You ve read the book... ... now test yourself
FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to
Medication Policy Manual. Topic: Betaseron, Extavia, interferon beta-1b Date of Origin: June 18, 2004
Medication Policy Manual Policy No: dru108 Topic: Betaseron, Extavia, interferon beta-1b Date of Origin: June 18, 2004 Committee Approval Date: December 12, 2014 Next Review Date: December 2015 Effective
Natalizumab (Tysabri)
Natalizumab (Tysabri) Spirella Building, Letchworth, SG6 4ET 01462 476700 www.mstrust.org.uk reg charity no. 1088353 Natalizumab (Tysabri) Date of issue: July 2010 Review date: July 2011 Contents Section
Kimberly Anderson-Erisman, PhD Director of Education University of Miami & Miami Project to Cure Paralysis
Webinar title: What is the Vibe? Vibration Therapy as a Rehabilitation Tool Presenter/presenters: Kimberly Anderson-Erisman, PhD Director of Education University of Miami & Miami Project to Cure Paralysis
AT&T Global Network Client for Windows Product Support Matrix January 29, 2015
AT&T Global Network Client for Windows Product Support Matrix January 29, 2015 Product Support Matrix Following is the Product Support Matrix for the AT&T Global Network Client. See the AT&T Global Network
New York State Workers' Comp Board. Mid and Lower Back Treatment Guidelines. Summary From 1st Edition, June 30, 2010. Effective December 1, 2010
New York State Workers' Comp Board Mid and Lower Back Treatment Guidelines Summary From 1st Edition, June 30, 2010 Effective December 1, 2010 General Principles Treatment should be focused on restoring
Tests For Predicting VO2max
Tests For Predicting VO2max Maximal Tests 1.5 Mile Run. Test Population. This test was developed on college age males and females. It has not been validated on other age groups. Test Procedures. A 1.5
Multifocal Motor Neuropathy. Jonathan Katz, MD Richard Lewis, MD
Multifocal Motor Neuropathy Jonathan Katz, MD Richard Lewis, MD What is Multifocal Motor Neuropathy? Multifocal Motor Neuropathy (MMN) is a rare condition in which multiple motor nerves are attacked by
AUBAGIO (teriflunomide) oral tablet
AUBAGIO (teriflunomide) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
Predicting Aerobic Power (VO 2max ) Using The 1-Mile Walk Test
USING A WALKING TEST 12/25/05 PAGE 1 Predicting Aerobic Power (VO 2max ) Using The 1-Mile Walk Test KEYWORDS 1. Predict VO 2max 2. Rockport 1-mile walk test 3. Self-paced test 4. L min -1 5. ml kg -1 1min
Multiple Sclerosis and Cooling
Multiple Sclerosis Association of America Multiple Sclerosis and Cooling Third Edition MSAA MSAA Multiple Sclerosis and Cooling Written by: Adam Roberts and Judith Harper-Bennie Edited by: Jack Burks,
CBT IN THE CITY. adjusted to the news of being with MS? April 2013. Experts at your fingertips call now. Check out our new services in you local area
April 2013 Experts at your fingertips call now CBT IN THE CITY Check out our new services in you local area contents. A message from Susie, Information Multiple Sclerosis CBT can make a difference on the
Multiple Sclerosis: What You Need To Know. For Professionals
Multiple Sclerosis: What You Need To Know For Professionals What will I learn today? The Basics: What is MS? Living with MS: A Family Affair We Can Help: The National MS Society What MS Is: MS is thought
ACCESS Nursing Programs Session 1 Center Valley Campus Only 8 Weeks Academic Calendar 8 Weeks
Session 1 Academic Calendar August 24, 2015 to October 17, 2015 Tuesday / Thursday, 5:30 pm to 8:30 pm M/W T/TH T/W TH S Saturday lab as scheduled Classes Begin 24-Aug 25-Aug 25-Aug 27-Aug 29-Aug NU205
ACCESS Nursing Programs Session 1 Center Valley Campus Only 8 Weeks Academic Calendar 8 Weeks
Session 1 Academic Calendar August 24, 2015 to October 17, 2015 Tuesday / Thursday, 5:30 pm to 8:30 pm M/W T/TH T/W TH S Saturday lab as scheduled Classes Begin 24-Aug 25-Aug 25-Aug 27-Aug 29-Aug NU205
Cervical Whiplash: Considerations in the Rehabilitation of Cervical Myofascial Injury. Canadian Family Physician
Cervical Whiplash: Considerations in the Rehabilitation of Cervical Myofascial Injury 1 Canadian Family Physician Volume 32, September 1986 Arthur Ameis, MD Dr. Ames practices physical medicine and rehabilitation,
March 30, 2007. I. IVIg IS AN ACCEPTED THERAPY FOR RRMS, AND IS PRESCRIBED ALONG WITH A DISEASE-MODIFYING AGENT SUCH AS COPAXONE
18 Timberline Drive Farmington, CT 06032 (860) 674-1370 (phone) (860) 674-1378 (fax) (860) 305-9835 (cell) www.advocacyforpatients.org [email protected] AZ Benefit Options ATTN: Appeals PO
Jill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
International Journal of Economics, Commerce and Management United Kingdom Vol. II, Issue 2, 2014
International Journal of Economics, Commerce and Management United Kingdom Vol. II, Issue 2, 2014 http://ijecm.co.uk/ ISSN 2348 0386 HEALTHCARE MANAGEMENT AND PSYCHOLOGICAL WELL-BEING IN PATIENTS WITH
Relapsing-remitting multiple sclerosis Ambulatory with or without aid
AVONEX/BETASERON/COPAXONE/EXTAVIA/GILENYA/REBIF/TYSABRI Applicant must be covered on an Alberta Government sponsored drug program. Page 1 of 5 PATIENT INFMATION Surname First Name Middle Initial Sex Date
Exercise Principles and Guidelines for Persons with Cerebral Palsy and Neuromuscular Disorders
Exercise Principles and Guidelines for Persons with Cerebral Palsy and Neuromuscular Disorders INTRODUCTION: Health and well being are the result of many factors: Physical activity is one of these factors.
advanced military training in hot weather such as ABN / Ranger School or ROTC camp.
Individual Guidance for Heat Acclimatization This heat acclimatization guidance is for those soldiers who will be attending strenuous advanced military training in hot weather such as ABN / Ranger School
Multiple Sclerosis Society of Canada. CADA Presentation May 4, 2011
Multiple Sclerosis Society of Canada CADA Presentation May 4, 2011 1 MS Society s Mission To be a leader in finding a cure for multiple sclerosis and enabling people affected by MS to enhance their quality
Trauma Insurance Claims Seminar Invitation
Trauma Insurance Claims Seminar Invitation Introduction Since the development of Trauma Insurance in Australia in the 1980s, the product has evolved at a great pace. Some of the challenges faced by claims
PCORI Workshop on Treatment for Multiple Sclerosis. Breakout Group Topics and Questions Draft 3-27-15
PCORI Workshop on Treatment for Multiple Sclerosis Breakout Group Topics and Questions Draft 3-27-15 Group 1 - Comparison across DMTs, including differential effects in subgroups Consolidated straw man
Understanding. Multiple Sclerosis. Tim, diagnosed in 2004.
Understanding Multiple Sclerosis Tim, diagnosed in 2004. What Is Multiple Sclerosis? Multiple sclerosis (MS) is a neurologic disorder that affects the central nervous system (CNS). The CNS includes the
2014 Neurologic Physical Therapy Professional Education Consortium Webinar Course Descriptions and Objectives
Descriptions and Neuroplasticity Health care providers are facing greater time restrictions to render services to the individual with neurological dysfunction. However, the scientific community has recognized
Lumbar Disc Herniation/Bulge Protocol
Lumbar Disc Herniation/Bulge Protocol Anatomy and Biomechanics The lumbar spine is made up of 5 load transferring bones called vertebrae. They are stacked in a column with an intervertebral disc sandwiched
Rational basis for early treatment in MS. Bonaventura Casanova Estruch Unitat d Esclerosi Múltiple Hospital Universitari la Fe València
Rational basis for early treatment in MS Bonaventura Casanova Estruch Unitat d Esclerosi Múltiple Hospital Universitari la Fe València Bonaventura Casanova Department of Neurology University Hospital La
EMG and the Electrodiagnostic Consultation for the Family Physician
EMG and the Electrodiagnostic Consultation for the Family Physician Stephanie Kopey, D.O., P.T. 9/27/15 The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Marketing Committee
Media Release. Basel, 8 October 2015
Media Release Basel, 8 October 2015 Roche s ocrelizumab first investigational medicine to show positive pivotal study results in both relapsing and primary progressive forms of multiple sclerosis Ocrelizumab
How To Cover Occupational Therapy
Guidelines for Medical Necessity Determination for Occupational Therapy These Guidelines for Medical Necessity Determination (Guidelines) identify the clinical information MassHealth needs to determine
Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest
Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest Cycle C June 2, 2015 1 Introduction The landscape for the treatment of relapsing Multiple Sclerosis (MS) has quickly evolved over
Neck Pain & Cervicogenic Headache Integrating Research into Practice: San Luis Sports Therapy s Approach to Evidence-Based Practice
Neck Pain & Cervicogenic Headache Integrating Research into Practice: San Luis Sports Therapy s Approach to Evidence-Based Practice PROBLEM: Neck Pain and Cervicogenic Headache 66% Proportion of individuals
Overtraining with Resistance Exercise
ACSM CURRENT COMMENT Overtraining with Resistance Exercise One of the fastest growing and most popular types of exercise in recent years is resistance exercise, whether used for the purpose of general
The Use of the Lokomat System in Clinical Research
International Neurorehabilitation Symposium February 12, 2009 The Use of the Lokomat System in Clinical Research Keith Tansey, MD, PhD Director, Spinal Cord Injury Research Crawford Research Institute,
Chapter 10. Summary & Future perspectives
Summary & Future perspectives 123 Multiple sclerosis is a chronic disorder of the central nervous system, characterized by inflammation and axonal degeneration. All current therapies modulate the peripheral
